Latest news
Traders Buy Large Volume of MoonLake Immunotherapeutics Call Options (NASDAQ:MLTX) - MarketBeatMarketBeat · Mon, 10 Aug 2026 15:14:33 GMTMoonLake Immunotherapeutics Announces Q2 2026 Financial Results with Increased Net Loss and Cash Reserves - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 13:59:59 GMTMoonLake Immunotherapeutics Announces Q2 2026 Financial Results and Positive Phase 3 IZAR-1 Trial Data for Sonelokimab in Psoriatic Arthritis - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 13:59:55 GMTMoonLake Immunotherapeutics 2Q 2026: Net loss $(61.8)M, EPS $(0.84) — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 11:51:01 GMTMoonLake Immunotherapeutics AG - Via RitzauVia Ritzau · Mon, 10 Aug 2026 11:00:00 GMTScinai Immunotherapeutics Ltd (SCNI) Stock News Today - TradingKeyTradingKey · Sat, 08 Aug 2026 01:54:07 GMTCertain Stock Options of MoonLake Immunotherapeutics are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.commarketscreener.com · Sat, 08 Aug 2026 00:22:39 GMTSCNI|Scinai Immunotherapeutics Ltd|Price:0.245|Chg%:-0.014 - TradingKeyTradingKey · Fri, 07 Aug 2026 07:00:00 GMT